ACM Biolabs
Latest round
- Series A
Last raised
- Jan 2021
Total raised
- $6.4M
Investors
- 5
About ACM Biolabs
Based in Singapore, and founded in 2013 by its CEO, Madhavan Nallani, ACM Biolabs Pte Ltd is a Biotech company engaged in the research and development of therapeutic vaccines for the treatment of infectious diseases. The firm has a subsidiary, ACM Biosciences that was launched in 2020 to cater to the international market. ACM Biolabs also has an office in Basel, Switzerland. The firm uses its proprietary ACM (artificial cell membrane) polymer-based technology to develop prophylactic and therapeutic vaccines for diseases such as cancer and covid. The firm's product pipeline includes ACM-OO1, which is a second-generation covid vaccine that’s tested to be effective against the disease’s newer variants including delta, and omicron. The company also offers vaccines for personalized cancer treatments.
Who invested in ACM Biolabs
5 investors across 2 rounds
See all investors in ACM Biolabs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ACM Biolabs
Who invested in ACM Biolabs?
ACM Biolabs has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ACM Biolabs raised?
ACM Biolabs has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ACM Biolabs last raise money?
ACM Biolabs's most recent round on record is a Series A, in Jan 2021.
What does ACM Biolabs do?
Based in Singapore, and founded in 2013 by its CEO, Madhavan Nallani, ACM Biolabs Pte Ltd is a Biotech company engaged in the research and development of therapeutic vaccines for the treatment of infectious diseases.
Where is ACM Biolabs headquartered?
ACM Biolabs is headquartered in Singapore, Singapore.
Which VCs invest in companies like ACM Biolabs?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ACM Biolabs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ACM Biolabs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.